Loftware has acquired PRISYM ID
January 18, 2022
Loftware has acquired PRISYM ID, a leading provider of regulated content and label management solutions with a focus on clinical trials, pharmaceutical and medical device labeling. The acquisition allows Loftware to expand its long-standing commitment to the medical device and pharmaceutical industries while expanding into the clinical trials labeling space, enabling customers to meet a broader set of requirements.
Acquiring an industry leading organization like PRISYM ID allows Loftware to strengthen its solutions and global services/support to deliver even more value to the medical device, pharmaceutical and clinical trials industries. It also strengthens Loftware’s overall ability in meeting labeling complexities and evolving regulatory demands for customers across ALL industries.
The acquisition brings together two thriving organizations, uniting the best talent in the medical device, pharmaceutical and now clinical trial labeling industries to apply unmatched domain expertise and fuel additional innovation. At the same time, the acquisition broadens Loftware’s cloud-based end-to-end platform, enabling us to meet a full range of requirements across Enterprise Labeling, Artwork Management, Clinical Trial Labeling and Regulated Product Content.
► Press Release